News

Dabigatran raises major bleeding risk

Posted on: 03/11/2014 - 21:00

Dabigatran significantly raises the risk of major bleeding and gastrointestinal bleeding across all subgroups of patients with atrial fibrillation, and particularly in African Americans and patients...

Field of Interest: Gastroentero...
Type: News Item

‘Chemo brain’ may have targetable causes

Posted on: 03/11/2014 - 15:46

BOSTON – The risk for cognitive decline following cancer treatment varies by both cancer and therapy types, and can range from subtle changes to severe deficits, according to a researcher. Patients...

Field of Interest: Oncology
Type: News Item

Vedolizumab rated first line for ulcerative colitis

Posted on: 02/11/2014 - 20:35

VIENNA  – Vedolizumab, a second-line biologic for treating patients who have ulcerative colitis or Crohn’s disease and don’t respond to an anti-tumor necrosis factor drug, is gaining traction...

Field of Interest: Gastroentero...
Type: News Item

VIDEO: Don’t discount topical therapy for psoriasis

Posted on: 02/11/2014 - 15:17

LAS VEGAS– Don’t underestimate the value of topical therapy for treating psoriasis patients, Dr. Linda Stein Gold said at Skin Disease Education Foundation’s annual Las Vegas dermatology...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More